411 A meta-analysis of the effects of interleukin-10 promoter gene polymorphisms on acute graft-versus-host disease susceptibility

Monday, October 22, 2012
Westin Diplomat Resort
InHye Cho, B.S., YunKyoung Song, M.S., Bo Yoon Choi, B.S and Jung Mi Oh, PharmD.
College of Pharmacy, Seoul National University, Seoul, South Korea

Purpose: The interleukin-10 (IL-10) is an important immunomodulatory cytokine that regulates the effect of other inflammatory mediators in many aspects of immune responses. IL-10 promoter gene polymorphic features have been documented to contribute to the susceptibility of acute graft-versus-host disease(aGVHD). However, results of previous studies are inconsistent and inconclusive. A meta-analysis was performed to evaluate the association between the IL-10 promoter gene polymorphisms in allogeneic hematopoietic stem cell transplantation (alloHSCT) patients and donors on the risk of aGVHD.

Methods: Up to April 2012, databases including MEDLINE, EMBASE and Cochrane Library were searched to access the relevant genetic association studies. A total of 22 studies that referred IL-10 promoter gene polymorphisms on aGVHD susceptibility were identified. The effect of the IL-10 genetic polymorphisms on aGVHD risk (grades I-IV, II-IV, and III-IV) were estimated from odds ratios (OR) with 95% confidence intervals (CI) for the dominant genetic model and recessive model, respectively. 

Results: IL-10 -819 CC genotype was associated with the increased aGVHD risk when compared with CT+TT genotype (grade I-IV: OR, 2.722, 95% CI, 1.360-5.450; grade II-IV: OR, 2.130, 95% CI, 1.322-3.430). Furthermore, patients with IL-10 -592 C genotype had an increased risk of grade II-IV aGVHD (CC vs. A: OR, 1.999, 95% CI, 1.230-3.250) and grade III-IV aGVHD (CC vs. A: OR,  1.276, 95% CI, 1.067-1.526; C vs. AA: OR, 1.419, 95% CI, 1.001-2.012; CC vs. AA: OR, 1.534, 95% CI, 1.076-2.185; C vs. A: OR, 1.180, 95% CI, 1.000-1.392). Patients who received grafts from donors with the IL-10 C allele experienced less frequent grade III-IV aGVHD (OR, 0.711, 95% CI, 0.508-0.996). 

Conclusion: This meta-analysis suggests that the -819C/T and -592C/A polymorphisms of IL-10 gene could be a risk factor for aGVHD in allo-HSCT patients. Moreover, our meta-analysis confirms the linkage disequilibrium between two single nucleotide polymorphisms (SNPs) as identified in other previous studies.